Group One Trading, L.P. Ardelyx, Inc. Transaction History

Group One Trading, L.P.

$2.68 Billion
Q2 2025

A detailed history of Group One Trading, L.P. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 288,961 shares of ARDX stock, worth $1.53 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

288,961

Previous 349,684 17.37%

Holding current value

$1.53 Million

Previous $1.72 Million 34.03%

% of portfolio

0.04%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$3.28 - $5.51 $199,171 - $334,583	-60,723 Reduced 17.37%	288,961 $1.13 Million
Q1 2025 May 14, 2025	SELL	$4.91 - $6.36 $466,906 - $604,791	-95,093 Reduced 21.38%	349,684 $1.72 Million
Q4 2024 Feb 14, 2025	SELL	$4.49 - $6.85 $727,020 - $1.11 Million	-161,920 Reduced 26.69%	444,777 $2.3 Million
Q3 2024 Nov 14, 2024	BUY	$5.28 - $7.57 $257,532 - $369,226	48,775 Added 8.74%	606,697 $4.18 Million
Q2 2024 Aug 14, 2024	BUY	$5.89 - $9.31 $3.29 Million - $5.19 Million	557,922 New	557,922 $4.13 Million
Q4 2023 Feb 14, 2024	BUY	$3.29 - $6.64 $371,908 - $750,598	113,042 Added 40.26%	393,805 $2.44 Million
Q3 2023 Nov 09, 2023	BUY	$3.3 - $4.83 $797,448 - $1.17 Million	241,651 Added 617.84%	280,763 $1.15 Million
Q2 2023 Aug 09, 2023	BUY	$3.23 - $4.95 $126,331 - $193,604	39,112 New	39,112 $132,000
Q3 2022 Nov 09, 2022	SELL	$0.59 - $1.44 $22,211 - $54,211	-37,647 Reduced 10.08%	336,018 $400,000
Q2 2022 Aug 11, 2022	BUY	$0.51 - $1.17 $89,019 - $204,222	174,549 Added 87.66%	373,665 $220,000
Q1 2022 May 12, 2022	SELL	$0.65 - $1.18 $138,990 - $252,321	-213,832 Reduced 51.78%	199,116 $213,000
Q4 2021 Feb 11, 2022	BUY	$0.86 - $1.7 $231,192 - $457,007	268,828 Added 186.53%	412,948 $454,000
Q3 2021 Nov 12, 2021	BUY	$1.27 - $8.17 $163,916 - $1.05 Million	129,068 Added 857.48%	144,120 $190,000
Q2 2021 Aug 10, 2021	BUY	$6.55 - $8.98 $98,590 - $135,166	15,052 New	15,052 $114,000
Q3 2020 Nov 12, 2020	SELL	$5.25 - $7.08 $9,828 - $13,253	-1,872 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$5.37 - $8.11 $74,170 - $112,015	-13,812 Reduced 88.06%	1,872 $13,000
Q1 2020 May 13, 2020	BUY	$4.35 - $8.79 $68,225 - $137,862	15,684 New	15,684 $89,000
Q4 2019 Feb 10, 2020	SELL	$4.23 - $8.29 $139,535 - $273,462	-32,987 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.15 - $6.28 $70,922 - $207,158	32,987 New	32,987 $155,000
Q1 2019 May 13, 2019	SELL	$1.88 - $3.35 $1,316 - $2,345	-700 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$1.66 - $4.16 $106 - $266	64 Added 10.06%	700 $1,000
Q3 2018 Nov 08, 2018	SELL	$3.75 - $4.65 $5,250 - $6,510	-1,400 Reduced 68.76%	636 $3,000
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.8 $3,833 - $6,008	1,036 Added 103.6%	2,036 $8,000
Q1 2018 May 11, 2018	SELL	$5.05 - $7.9 $4,040 - $6,320	-800 Reduced 44.44%	1,000 $5,000
Q4 2017 Feb 09, 2018	BUY	$4.85 - $7.8 $1,939 - $3,120	400 Added 28.57%	1,800 $12,000
Q3 2017 Nov 15, 2017	SELL	$4.35 - $5.7 $5,959 - $7,809	-1,370 Reduced 49.46%	1,400 $8,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,770	2,770 $14,000

Others Institutions Holding ARDX

# of Institutions

222

Shares Held

167M

Call Options Held

517K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $816M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Ardelyx, Inc. Transaction History